CAS 2202-01-9: 1H-Benz[e]indene-6-propanoic acid,dodecahydro-6,9a,9b-trimethyl-7-[(1S)- 1-methylethenyl]-3-(tetrahydro-2-methyl-5- oxo-2-furanyl)-,(3S,3aR,5aR,6S,7R,9aR,- 9bR)-

Eichlerialactone is a natural compound, which is a secondary metabolite isolated from fungi. It is derived specifically from species of the genus *Eichleria*, known for their complex biochemical capabilities. The compound exhibits intriguing biological activities through its specific mode of action involving modulation of cellular pathways, potentially by interacting with specific molecular targets. This mode of action suggests its potential as a lead compound for drug discovery, especially in the search for novel therapeutic agents. Eichlerialactone has garnered interest due to its promising pharmacological properties, which may include antimicrobial, anticancer, or anti-inflammatory effects, although these require further empirical validation. In the realm of natural products chemistry and pharmacology, it is studied for its potential to provide insights into novel mechanisms of action that could lead to the development of new classes of therapeutics. Scientists are particularly focused on elucidating its biosynthetic pathway, exploring its structure-activity relationships, and understanding its full range of biological effects through rigorous pharmacological studies and bioassays.

Eichlerialactone, ethyl eichlerianoate fight tuberculosis (25-50ug/mL). First also kills Gram-positive bacteria, weakly toxic to BC cells.